Genotyping of Trypanosoma cruzi DTUs and Trypanosoma rangeli genetic groups in experimentally infected Rhodnius prolixus by PCR-RFLP

Acta Tropica ◽  
2016 ◽  
Vol 156 ◽  
pp. 115-121 ◽  
Author(s):  
Amanda R.N. Sá ◽  
Greicy B.M. Dias ◽  
Karen Y. Kimoto ◽  
Mário Steindel ◽  
Edmundo C. Grisard ◽  
...  
PLoS ONE ◽  
2014 ◽  
Vol 9 (8) ◽  
pp. e105255 ◽  
Author(s):  
Maria Raquel Fellet ◽  
Marcelo Gustavo Lorenzo ◽  
Simon Luke Elliot ◽  
David Carrasco ◽  
Alessandra Aparecida Guarneri

2018 ◽  
Vol 11 (1) ◽  
Author(s):  
Azael Saldaña ◽  
Ana María Santamaría ◽  
Vanessa Pineda ◽  
Vanessa Vásquez ◽  
Nicole L. Gottdenker ◽  
...  

2005 ◽  
Vol 77 (3) ◽  
pp. 397-404 ◽  
Author(s):  
Patrícia Azambuja ◽  
Norman A. Ratcliffe ◽  
Eloi S. Garcia

This review outlines aspects on the developmental stages of Trypanosoma cruzi and Trypanosoma rangeli in the invertebrate host, Rhodnius prolixus. Special attention is given to the interactions of these parasites with gut and hemolymph molecules and the effects of the organization of midgut epithelial cells on the parasite development. The vector insect's permissiveness to T. cruzi, which develops in the vector gut, largely depends on the host nutritional state, the parasite strain and the molecular interactions with trypanolytic compounds, lectins and resident bacteria in the gut. T. rangeli invades the hemocoel and once in the hemolymph, can be recognized and activates the defense system of its insect vector, i.e., the prophenoloxidase system, phagocytosis, hemocyte microaggregation, superoxide and nitric oxide activity and the eicosanoid biosynthesis pathway. Taken together, these findings not only provide a better understanding of the interactions parasite - insect vector, but also offer new insights into basic physiological processes involved in the parasites transmission.


1995 ◽  
Vol 65 (3) ◽  
pp. 261-268 ◽  
Author(s):  
C.B. Mello ◽  
E.S. Garcia ◽  
N.A. Ratcliffe ◽  
P. Azambuja

Parasitology ◽  
2016 ◽  
Vol 143 (9) ◽  
pp. 1157-1167 ◽  
Author(s):  
JENNIFER K. PETERSON ◽  
ANDREA L. GRAHAM ◽  
RYAN J. ELLIOTT ◽  
ANDREW P. DOBSON ◽  
OMAR TRIANA CHÁVEZ

SUMMARYTrypanosoma cruzi, causative agent of Chagas disease, co-infects its triatomine vector with its sister species Trypanosoma rangeli, which shares 60% of its antigens with T. cruzi. Additionally, T. rangeli has been observed to be pathogenic in some of its vector species. Although T. cruzi–T. rangeli co-infections are common, their effect on the vector has rarely been investigated. Therefore, we measured the fitness (survival and reproduction) of triatomine species Rhodnius prolixus infected with just T. cruzi, just T. rangeli, or both T. cruzi and T. rangeli. We found that survival (as estimated by survival probability and hazard ratios) was significantly different between treatments, with the T. cruzi treatment group having lower survival than the co-infected treatment. Reproduction and total fitness estimates in the T. cruzi and T. rangeli treatments were significantly lower than in the co-infected and control groups. The T. cruzi and T. rangeli treatment group fitness estimates were not significantly different from each other. Additionally, co-infected insects appeared to tolerate higher doses of parasites than insects with single-species infections. Our results suggest that T. cruzi–T. rangeli co-infection could ameliorate negative effects of single infections of either parasite on R. prolixus and potentially help it to tolerate higher parasite doses.


Sign in / Sign up

Export Citation Format

Share Document